Chemokine Profile Is Different in Normal Testis Compared to Seminoma - Especially in Tumor Infiltrating Lymphocytes.

Autor: Händelin JM; Department of Medicine, University of Oulu, Oulu, Finland; jonas.handelin@student.oulu.fi., Teppo HR; Department of Medicine, University of Oulu, Oulu, Finland.; Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland., Haapasaari KM; Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland., Ollikainen RK; Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.; Cancer Centre, Oulu University Hospital, Oulu, Finland., Kemppainen J; Department of Medicine, University of Oulu, Oulu, Finland., Kuitunen H; Cancer Centre, Oulu University Hospital, Oulu, Finland., Kuittinen O; Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.; Department of Clinical Oncology, Institute of Clinical Medicine, Kuopio University Hospital, Kuopio, Finland., Kuusisto MEL; Cancer Research and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.; Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.; Department of Internal Medicine, Länsi-Pohja Central Hospital, Kemi, Finland.

Publikováno v: Anticancer research [Anticancer Res] 2024 Nov; Vol. 44 (11), pp. 4961-4967.

Survival of patients with classical Hodgkin lymphoma in Finland: a national population-based analysis.

Autor: Hannuksela N; Oncology, Faculty of Health Medicine, School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland. nhannuks@student.uef.fi., Partanen A; Department of Medicine, Kuopio University Hospital, Wellbeing Services County of Northern Savo, Kuopio, Finland., Anttalainen A; Medaffcon Oy, Espoo, Finland., Ukkola-Vuoti L; Medaffcon Oy, Espoo, Finland., Toppila I; Medaffcon Oy, Espoo, Finland., Vikkula J; Medaffcon Oy, Espoo, Finland., Marin K; Department of Oncology, Kuopio University Hospital, Kuopio, Finland., Kuitunen H; Cancer Center, Oulu University Hospital, Oulu, Finland., Miettinen T; Takeda Oy, Helsinki, Finland., Kuittinen O; Oncology, Faculty of Health Medicine, School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.; Department of Oncology, Kuopio University Hospital, Kuopio, Finland., Rönkä A; Oncology, Faculty of Health Medicine, School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.; Department of Oncology, Kuopio University Hospital, Kuopio, Finland.

Publikováno v: Blood cancer journal [Blood Cancer J] 2024 Aug 20; Vol. 14 (1), pp. 139. Date of Electronic Publication: 2024 Aug 20.

Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis.

Autor: Harmanen M; University of Eastern Finland, Faculty of Health Sciences Medicine, School of Medicine, Institute of Clinical Medicine, Kuopio, Finland., Sorigue M; Medical Department, Trialing Health, Barcelona, Spain., Khan M; University of Eastern Finland, Faculty of Health Sciences Medicine, School of Medicine, Institute of Clinical Medicine, Kuopio, Finland., Prusila R; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland., Klaavuniemi T; Department of Oncology, Mikkeli Central Hospital, Mikkeli, Finland., Kari E; Department of Oncology, Tampere University Hospital, Tampere Cancer Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Jantunen E; Department of Medicine, University of Eastern Finland, Institute of Clinical Medicine/Internal Medicine, Hospital District of North Carelia, Kuopio University Hospital, Kuopio, Finland.; Department of Medicine, Kuopio University Hospital, Kuopio, Finland., Sunela K; Department of Oncology, Tampere University Hospital, Tampere Cancer Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Rajamäki A; University of Eastern Finland, Faculty of Health Sciences Medicine, School of Medicine, Institute of Clinical Medicine, Kuopio, Finland.; Department of Oncology, Hospital Nova of Central Finland, Jyväskylä, Finland., Alanne E; Department of Oncology and Radiotherapy, Turku University Hospital, Western Finland Cancer Centre, Turku, Finland., Kuitunen H; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland., Jukkola A; Department of Oncology, Tampere University Hospital, Tampere Cancer Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Sancho JM; University of Eastern Finland, Faculty of Health Sciences Medicine, School of Medicine, Institute of Clinical Medicine, Kuopio, Finland.; Department of Hematology, ICO-Badalona, IJC, UAB, Hospital Germans Trias i Pujol, Badalona, Spain., Kuittinen O; Department of Oncology, Kuopio University Hospital, Kuopio, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Rönkä A; Department of Oncology, Kuopio University Hospital, Kuopio, Finland.

Publikováno v: European journal of haematology [Eur J Haematol] 2024 Aug; Vol. 113 (2), pp. 218-226. Date of Electronic Publication: 2024 Apr 25.

Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.

Autor: Pulczynski EJ; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark; Department of Haematology, Region Hospital Goedstrup, Herning., Simonsen MR; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Mathematical Sciences, Aalborg University, Aalborg., Kuittinen O; Department of Oncology, Kuopio University Hospital Cancer Center, Kuopio, Finland; Faculty of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio., Fagerli UM; Department of Oncology, St Olav University Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of science and technology (NTNU), Trondheim, Norway., Erlanson M; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Fluge Ø; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Leppä S; Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki., Østenstad B; Department of Oncology, Oslo University Hospital, Oslo, Norway., Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B-cell Malignancies, University of Oslo, Oslo, Norway., Eriksson M; Department of Oncology, Skane University Hospital, Lund, Sweden; Medical Oncology, Lund University, Lund, Sweden., El-Galaly T; Department of Hematology, Aalborg University Hospital, Aalborg., Kuitunen H; Cancer Centre, Oulu University Hospital, Oulu., Papworth K; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Ljungqvist M; Department of Clinical Science and Education, Södersjukhuste, Karolinska Insitutet, Stockholm, Sweden; Haematology Centre, Karolinska University Hospital, Stockholm, Sweden., Pedersen MB; Department of Haematology, Aarhus University Hospital, Aarhus., Pollari M; Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere. marjukka.pollari@pirha.fi.

Publikováno v: Haematologica [Haematologica] 2024 Jul 01; Vol. 109 (7), pp. 2359-2363. Date of Electronic Publication: 2024 Jul 01.

Gut microbiome-derived bacterial extracellular vesicles in patients with solid tumours.

Autor: Mishra S; Research Unit of Translational Medicine, University of Oulu, Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland. Electronic address: surbhi.mishra@oulu.fi., Tejesvi MV; Biocenter Oulu, University of Oulu, Oulu, Finland; Ecology and Genetics, Faculty of Science, University of Oulu, Oulu, Finland., Hekkala J; Research Unit of Translational Medicine, University of Oulu, Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland., Turunen J; Research Unit of Translational Medicine, University of Oulu, Oulu, Finland; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland., Kandikanti N; Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland., Kaisanlahti A; Research Unit of Translational Medicine, University of Oulu, Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland., Suokas M; Biocenter Oulu, University of Oulu, Oulu, Finland., Leppä S; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland., Vihinen P; FICAN West Cancer Centre and Department of Oncology, Turku University Hospital and University of Turku, 20521 Turku, Finland., Kuitunen H; Department of Oncology, Oulu University Hospital, Oulu, Finland., Sunela K; Finnish Medicines Agency, Tampere, Finland., Koivunen J; Department of Medical Oncology and Radiotherapy and Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland., Jukkola A; Tampere Cancer Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Kalashnikov I; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland; Research Program Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Auvinen P; Cancer Center, Kuopio University Hospital, Northern Savonia Healthcare Municipality, Kuopio, Finland., Kääriäinen OS; Cancer Center, Kuopio University Hospital, Northern Savonia Healthcare Municipality, Kuopio, Finland., Peñate Medina T; Section Biomedical Imaging, Department of Radiology and Neuroradiology and Institute for Experimental Cancer Research, Kiel University, 24105 Kiel, Germany., Peñate Medina O; Section Biomedical Imaging, Department of Radiology and Neuroradiology and Institute for Experimental Cancer Research, Kiel University, 24105 Kiel, Germany; Lonza Netherlands B.V., 6167 RB Geleen, the Netherlands., Saarnio J; Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland., Meriläinen S; Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland., Rautio T; Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland., Aro R; Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland., Häivälä R; Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland., Suojanen J; Päijät-Häme Joint Authority for Health and Wellbeing, Department of Oral and Maxillofacial Surgery, Lahti Central Hospital, 15850 Lahti, Finland; Cleft Palate and Craniofacial Centre, Department of Plastic Surgery, Helsinki University Hospital, 00029 Helsinki, Finland; Clinicum, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Laine M; Department of Abdominal Surgery, Porvoo Hospital, Hospital District of Helsinki and Uusimaa, Porvoo, Finland., Erawijattari PP; Department of Computing, University of Turku, Turku, Finland., Lahti L; Department of Computing, University of Turku, Turku, Finland., Karihtala P; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland; Department of Oncology, Oulu University Hospital, Oulu, Finland., Ruuska TS; Biocenter Oulu, University of Oulu, Oulu, Finland; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland; Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland., Reunanen J; Research Unit of Translational Medicine, University of Oulu, Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland.

Publikováno v: Journal of advanced research [J Adv Res] 2024 Mar 07. Date of Electronic Publication: 2024 Mar 07.